US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

205.96

-4.5700-2.17%

Post-market: 206.500.5400+0.26%19:30 EDT

Volume:1.55M

Turnover:321.61M

Market Cap:10.45B

PE:32.63

High:211.73

Open:210.09

Low:205.84

Close:210.53

52wk High:217.12

52wk Low:144.65

Shares:50.75M

Float Shares:50.75M

Volume Ratio:1.07

T/O Rate:3.05%

Dividend:0.34

Dividend Rate:0.16%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.28

PE(LYR):5.83

Loading ...

Overview Company News Filings

Vortex Energy Expands Saskatchewan Portfolio with Meadows Project Acquisition

Vertex adds AI-focused independent director to board

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Sector Update: Healthcare

MT Newswires Live

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.21% on Oct 1: What Investors Need To Know

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-01

Sector Update: Healthcare

MT Newswires Live

Regeneron price target raised to $930 from $870 at Jefferies

Amgen’s Pediatric Psoriasis Study in Japan Wraps Up, Setting the Stage for Otezla Growth

Expanded Sanofi agreement particularly favorable for Regeneron, says TD Cowen

Walt Disney, Amgen Share Losses Lead Dow's 150-Point Fall

Regeneron says COURAGE trial confirms trevogrumab prevents muscle loss

Regeneron Pharmaceuticals, - 9-Month Median Duration of Response Observed at 800 Mg Ubamatamab Dose

THOMSON REUTERS

Regeneron Pharmaceuticals, - Ubamatamab Shows 73% Objective Response Rate and 11-Month Median Pfs in Lgsoc Patients

THOMSON REUTERS

Regeneron Pharmaceuticals, - Serious Teaes Grade 3+ in 21% of Lgsoc Patients; Traes in 74%; Neutropenia, Anemia, Elevated Liver Enzymes

THOMSON REUTERS

Regeneron Pharmaceuticals, - to Advance Ubamatamab into Confirmatory Phase 3 Trial for Lgsoc

THOMSON REUTERS

Ubamatamab (Muc16xcd3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (Lgsoc)

THOMSON REUTERS

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IBB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":205.96,"timestamp":1790884800000,"preClose":210.53,"halted":0,"volume":1546879,"hourTrading":{"tag":"盘后","latestPrice":206.5,"preClose":205.96,"latestTime":"19:30 EDT","volume":7495,"amount":1543811.2559,"timestamp":1790897406046,"change":0.54,"changeRate":0.002622,"amplitude":0.008885},"delay":0,"changeRate":-0.021707120125397772,"floatShares":50750000,"shares":50750000,"eps":6.311863,"marketStatus":"Post-Mkt","change":-4.57,"latestTime":"10-01 19:56:25 EDT","open":210.085,"high":211.73,"low":205.84,"amount":321610885.85687,"amplitude":0.027977,"askPrice":207,"askSize":10,"bidPrice":206,"bidSize":20,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":210.53,"sharesOutstanding":49450000,"nav":211.023541,"aum":11226452381.2,"dividendRate":0.001637,"bidAskSpread":0.000363,"preHourTrading":{"tag":"盘前","latestPrice":210,"preClose":210.53,"latestTime":"09:27 EDT","volume":198,"amount":41672.93328,"timestamp":1790861278000,"change":-0.53,"changeRate":-0.002517,"amplitude":0.010126},"postHourTrading":{"tag":"盘后","latestPrice":206.5,"preClose":205.96,"latestTime":"19:30 EDT","volume":7495,"amount":1543811.2559,"timestamp":1790897406046,"change":0.54,"changeRate":0.002622,"amplitude":0.008885},"volumeRatio":1.06677,"impliedVol":0.2407,"impliedVolPercentile":0.5976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50750000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.06677,"shares":50750000,"dividePrice":0.3371,"high":211.73,"amplitude":0.027977,"preClose":210.53,"low":205.84,"week52Low":144.65,"pbRate":"1.28","psRate":"251.48","week52High":217.12,"institutionHeld":0,"latestPrice":205.96,"committee":0.333333,"eps":6.311863,"divideRate":0.001637,"volume":1546879,"delay":0,"ttmEps":6.311863,"open":210.085,"prevYearClose":168.77,"prevWeekClose":209.77,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":209.25,"twentyDayClose":213.8,"sixtyDayClose":196.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672760388","title":"Vortex Energy Expands Saskatchewan Portfolio with Meadows Project Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2672760388","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672760388?lang=en_us&edition=fundamental","pubTime":"2026-10-02 06:02","pubTimestamp":1790892167,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has shared an announcement. Vortex Energy Corp. has completed the acquisition of the Meadows Project in west-ce...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-expands-saskatchewan-portfolio-with-meadows-project-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-expands-saskatchewan-portfolio-with-meadows-project-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","SG9999001176.SGD","SG9999013999.USD","BK4139","IE00B2B36J28.USD","IE00B4R5TH58.HKD","SG9999001176.USD","LU2237438978.USD","LU2462157665.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","LU0079474960.USD","LU2362541273.HKD","BIB","IE0002270589.USD","LU1778281490.HKD","IDNA","LU1069344957.HKD","IE00BZ9MQY76.HKD","LU0889565916.HKD","LU2236285917.USD","LU1035775433.USD","GNMX","PBE","VRTX","SGXZ57979304.SGD","BK4588","LU1585245621.USD","LU0320765992.SGD","IE00B19Z9P08.USD","LU2456880835.USD","IE0009355771.USD","BK4567","IE0002141913.USD","IBBQ","LU0823416689.USD","LU1674673691.USD","LU2362540622.SGD","LU0234570918.USD","BK4532","TBXU","IE00BJJMRZ35.SGD","BK4585","IE00B19Z3B42.SGD","LU1093756325.SGD","LU1430594728.SGD","BBH","LU2089984988.USD","LU2324357040.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672767548","title":"Vertex adds AI-focused independent director to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2672767548","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672767548?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:01","pubTimestamp":1790888516,"startTime":"0","endTime":"0","summary":"Vertex ( ($VERX) ) has issued an announcement. On September 30, 2026, Vertex’s Board of Directors elected Debanjan Saha, Chief Executive Officer of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-adds-ai-focused-independent-director-to-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-adds-ai-focused-independent-director-to-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","BK4588","LU0234570918.USD","BK4585","LU1674673428.USD","LU0256863811.USD","BK4533","GNMX","TBXU","LU2468319806.SGD","VTHR","LU0417517546.SGD","SG9999001176.SGD","SG9999001176.USD","BK4567","LU0109394709.USD","IE0009355771.USD","LU2462157665.USD","LU2089984988.USD","IE00B19Z9P08.USD","LU2236285917.USD","SGXZ57979304.SGD","BIB","LU2362540622.SGD","IE0002270589.USD","IE00B19Z9Z06.USD","AGIX","VRTX","LU0079474960.USD","IE00B2B36J28.USD","BK4139","VERX","LU2362541513.USD","LU1674673691.USD","BK4023","IE00BJJMRZ35.SGD","PBE","BBH","LU0566484027.USD","LU1585245621.USD","LU0320765992.SGD","LU1778281490.HKD","LU2237438978.USD","IDNA","AIPO","IBBQ","QTOC","IE00B4R5TH58.HKD","ARTY","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","NVIB","IEIH","NANO","IBB","RSPH","DARP","FWD","AGNG","BK4588","JDOC","FHLC","XBIX","LNGR","BBP","BK4585","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672788764","title":"Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2672788764","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672788764?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:15","pubTimestamp":1790885725,"startTime":"0","endTime":"0","summary":"• Amgen faced intraday downward pressure and profit-taking after rallying to multi-year highs.\n• Core commercial volume growth remained strong alongside ongoing headwinds from biosimilar competition.\n• Technical indicators show a neutral MACD of 5.033 and an RSI of 50.194.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262196878-market-movers-amgn-20261001","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","04332","PJP","IE0009355771.USD","LU0320765992.SGD","BK4599","LU0889565916.HKD","AMGN","LU0109394709.USD","IE00B4R5TH58.HKD","PBE","LU2468319806.SGD","SG9999001440.SGD","LU1057294990.SGD","TBXU","IE00BJJMRZ35.SGD","IE0002141913.USD","LU2242652126.USD","LU0122379950.USD","IE00B2B36J28.USD","LU1023059063.AUD","BK4581","BK4533","BK4139","LU1983299246.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU0289739699.SGD","IBBQ","BIB","IE00BJT1NW94.SGD","BK4585","LU2089984988.USD","IBB","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","BBH","BK4534","BK4588","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672761731","title":"S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2672761731","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672761731?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:30","pubTimestamp":1790883008,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeAccenture PLCACN.N+17.9%Synopsys, Inc.SNPS.OQ+13.2%Fair Isaac CorporationFICO.N+12.8%Coher","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL8N45N1YY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","IE00BZ9MQY76.HKD","SG9999014914.USD","LU0079474960.USD","FDIQ","COHR","FICO","VRTX","EGGY","COHC","IE00B64QTZ34.USD","PBE","TBXU","COHH","IE0002270589.USD","LU1035775433.USD","IDNA","SGXZ23171101.USD","SG9999017495.SGD","COHX","GNMX","COHQ","LU1989772923.USD","LU0072462343.USD","LU1778281490.HKD","SG9999013999.USD","SG9999014880.SGD","PSKY","LU1061106388.HKD","LU1989764664.SGD","INCY","LU2125909593.SGD","IBBQ","BIB","SG9999001176.USD","LUMA","MKC","SPRX","PRNT","IBB","LU1923623000.USD","CTSH","FMED","FOTO","BBH","SNPX","SNPS","IE00BZ199S13.USD","ACN","DHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672783761","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672783761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672783761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:29","pubTimestamp":1790882992,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  dropping 1.1%.The iShares Biotechnology ETF  shed 1.6%.In corporate news, Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909 into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial. Foghorn shares fell 16%, and Lilly was down 0.2%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","LU0266013472.USD","LU0353189680.USD","LU0820562030.AUD","LU2087625088.SGD","LU2237438978.USD","IE00BJT1NW94.SGD","LU2746668974.SGD","LU2211815571.USD","VHT","LLYX","LU2168564495.EUR","IE00BKPKM429.USD","IE00BFSS7M15.SGD","LLYZ","LU2089283258.USD","LU0320765059.SGD","SG9999001176.USD","LU1093756325.SGD","LU0097036916.USD","IE00BJJMRX11.SGD","IE00B4JS1V06.HKD","LU2028103732.USD","LU2271345857.HKD","LU1623119135.USD","LU1145028129.USD","LU1868837300.USD","LU0672654240.SGD","LU0106261372.USD","LU0820561909.HKD","FHLC","LU1232071149.USD","LU2023250330.USD","IE0001KFT4U8.USD","LU1291159041.SGD","LU0234572021.USD","LU2168563687.JPY","LU2462157665.USD","LU2357305700.SGD","IXJ","LU2468319806.SGD","LU1280957306.USD","LU2491050071.SGD","LU2896262040.SGD","LU2237443465.HKD","LU2063271972.USD","OZEM","LU1720051017.SGD","BK4599","LU2746668461.USD","TRUH","LU2361044949.HKD","LU2168564222.USD","LU0158827781.USD","SG9999014914.USD","JDOC","TMED","GB00BDT5M118.USD","IE00B1XK9C88.USD","IE0009355771.USD","HRTS","LU1267930730.SGD","LU2265009873.SGD","LU1023059063.AUD","LU1988902786.USD","LU0096364046.USD","LU1814569148.SGD","LU2491049909.HKD","LU1720051108.HKD","SGXZ57979304.SGD","BK4516","SG9999018865.SGD","LU0210536198.USD","LU0158827948.USD","IE00BKDWB100.SGD","LU2112291526.USD","LU0198837287.USD","LU1989771016.USD","IE00B4R5TH58.HKD","SG9999013999.USD","LU0640476718.USD","LU2236285917.USD","LU1551013342.USD","SG9999018857.SGD","LU0786609619.USD","LU0109391861.USD","IE0004445239.USD","LU1868837136.USD","AGNG","IE00B1BXHZ80.USD","LU0256863902.USD","LU0820561818.USD","LU0471298694.HKD","LU2361044865.SGD","IE00BK4W5L77.USD","FHTX","IE00B2B36J28.USD","LU1551013425.SGD","LU1061106388.HKD","MEDX","LLY","LU2756315664.SGD","LU1868836757.USD","CURE","IE00B775H168.HKD","BK4588","LU0471298777.SGD","LU0094547139.USD","IE00B7KXQ091.USD","SG9999014880.SGD","LU2108987350.USD","LU2471134952.CNY","MHIP","LU2417539215.USD","BK4534","LU2461242641.AUD","LU0889565916.HKD","LABU","SG9999014906.USD","LU1035775433.USD","GDOC","LU1974910355.USD","LU2552382215.SGD","LU0256863811.USD","LU0345770993.USD","IHE","LU2456880835.USD","LU0225283273.USD","PJP","LU2237443549.SGD","LU2552382132.HKD","IE0005OL40V9.USD","LU2471134879.HKD","LU0238689110.USD","BK4007","LU2552382058.USD","LU1868836914.USD","LU0203202063.USD","LU0354030511.USD","IYH","LU2106854487.HKD","SGXZ99366536.SGD","LU2602419157.SGD","LU0109394709.USD","LU0964807845.USD","IE00BFSS8Q28.SGD","LU0417517546.SGD","LU2213496289.HKD","LU0114720955.EUR","LU0058720904.USD","LU1093756168.USD","LU2089284900.SGD","LLII","SG9999014898.SGD","IE00BFTCPJ56.SGD","LU0466842654.USD","FTXH","XLV","LU0882574139.USD","LU0353189763.USD","LU0079474960.USD","LU0174119429.USD","LU2168564065.EUR","SG9999001176.SGD","LU2491050154.USD","LU0708995401.HKD","LU0320765992.SGD","LU2111349929.HKD","WDNA","LU0354030438.USD","LU0385154629.USD","LU0316494557.USD","LU0061475181.USD","LU1064131342.USD","LU2237443622.USD","SGXZ81514606.USD","THNR","BK4139","LU2237443382.USD","IBB","IE00BJJMRZ35.SGD","LU1712237335.SGD","LU1366192091.USD","LU0787776722.HKD","IE0002141913.USD","LU1804176565.USD","LU2750360641.GBP","LU0689472784.USD","LU1983299246.USD","LU0823434740.USD","LU1691799644.USD","LU2237443895.HKD","MEDI","SG9999015952.SGD","SGXZ31699556.SGD","LU1548497426.USD","XBI","LU0432979614.USD","LU0683600562.USD","LU0882574055.USD","LU2023250504.SGD","LU2089984988.USD","LU2237443978.SGD","LU2756315318.SGD","LU1057294990.SGD","LU2023251221.USD","IE00BN29S564.USD","SGXZ51526630.SGD","LU1868836591.USD","LU2361045086.USD","IE0004445015.USD","LU2750360997.AUD","LU2471134796.USD","LU0823434583.USD","LU0006306889.USD","LU1127390331.HKD","LU1629891620.HKD","PPH","LU1979441026.SGD","SG9999015986.USD","IE00BJJMRY28.SGD","IE00BK4W5M84.HKD","LU0345770308.USD","ELIL","BK4585","IE00BWXC8680.SGD","LU0122379950.USD","LU2168564149.EUR","LU2360106947.USD","SG9999017495.SGD","LU0823416689.USD","LU2324357040.USD","LU0289739699.SGD","CANC","LU2462591350.SGD","ELIS","LU1917777945.USD","ILDR","LU1069344957.HKD","LU1323610961.USD","LU0323591593.USD","BK4533","SG9999015945.SGD","LU0203201768.USD","LU0133085943.USD","SG9999015978.USD","LU2264538146.SGD","LU2471134523.USD","IE00BJLML261.HKD","LU0943347566.SGD","RXL","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672761445","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.21% on Oct 1: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2672761445","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672761445?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:15","pubTimestamp":1790882127,"startTime":"0","endTime":"0","summary":"• Elevated treasury yields and high valuations caused downward pressure on Vertex shares.\n• The Crinetics acquisition drove investor focus toward capital deployment and integration efficiency.\n• Technical indicators show a MACD sell signal and an oversold Williams %R.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262196789-market-movers-vrtx-20261001","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","IE00BZ9MQY76.HKD","LU2362541513.USD","IE0009355771.USD","LU0320765992.SGD","LU1069344957.HKD","LU0079474960.USD","LU0889565916.HKD","LU0109394709.USD","LU0823416689.USD","LU2324357040.USD","LU2417539215.USD","VRTX","LU2462157665.USD","IE00B894F039.SGD","IE00B4R5TH58.HKD","PBE","LU2468319806.SGD","TBXU","IE00BJJMRZ35.SGD","IE0002141913.USD","IE0002270589.USD","LU1035775433.USD","IDNA","LU2456880835.USD","IE00B19Z3581.USD","LU1674673428.USD","GNMX","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU1585245621.USD","LU1778281490.HKD","SG9999013999.USD","LU0234570918.USD","LU2236285917.USD","BK4533","BK4139","LU1430594728.SGD","LU0289739699.SGD","SG9999001176.USD","IBBQ","BIB","LU0417517546.SGD","IE00BJT1NW94.SGD","LU0432979614.USD","BK4585","LU1093756168.USD","LU2089984988.USD","LU0061475181.USD","LU0256863811.USD","LU2237438978.USD","IBB","LU2362541273.HKD","SG9999001176.SGD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","BBH","LU2362540622.SGD","LU1093756325.SGD","BK4567","BK4588","LU1674673691.USD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672276152","title":"NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-01","url":"https://stock-news.laohu8.com/highlight/detail?id=2672276152","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672276152?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:45","pubTimestamp":1790880306,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-10-01Nasdaq 100.NDXTop PerformersPercent ChangeSynopsys, Inc.SNPS.OQ+12.9%Lumentum Holdings Inc.LITE.OQ+7.1%Cadence Desig","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL8N45N1VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSTX","LU1923622614.USD","IE0034235188.USD","MSTP","LU0061475181.USD","BK4539","LU1804176565.USD","APP","FOTO","IE00B2B36J28.USD","BK4020","04332","03455","LU0728928796.USD","LU0432979614.USD","IE0002270589.USD","LU2097829019.USD","IE00B19Z9Z06.USD","LU0266013472.USD","MSTZ","LU1623119135.USD","ROP","SQQQ","07261","IE00B1B80R65.USD","IE00B0169N27.USD","LU1868838027.USD","LU0107464264.USD","SG9999001176.USD","SGXZ57979304.SGD","LU2250418816.HKD","LITC","IE00B5949003.HKD","07399","IDNA","LU2211815571.USD","BK4599","LU1861220033.SGD","LU1861220207.SGD","LU1989764748.USD","IE0009355771.USD","LU0472753341.HKD","LITZ","APED","LU2362540622.SGD","IE00B4R5TH58.HKD","LU0868486357.SGD","LU0053687314.USD","BK4009","MSTY.UK","LU0302445910.USD","SG9999001440.SGD","CLOD","LU2247934214.USD","BK4220","LU0205194284.USD","LU2087625088.SGD","LU2125909247.SGD","LU2125909916.SGD","LU2098885051.SGD","LU2210149790.SGD","LU2360107671.USD","LU0431992006.USD","BK4516","LU2468319806.SGD","WNTR","LUMA","BK4548","LU0256863811.USD","LITU","LU1323610961.USD","SMI3.UK","ONLN","SG9999013999.USD","LU0109394709.USD","LU2506952410.USD","LU2249611893.SGD","LU0240878834.USD","LU1951198990.SGD","LU0069063385.USD","LU1868837565.USD","03034","LU0417517546.SGD","LU2294711713.HKD","BBH","LU0289961442.SGD",".IXIC","MSTY","LU1674673691.USD","MSTR","09799","IE00B894F039.SGD","LU0348723411.USD","LU2242646821.SGD","LU0058720904.USD","IE0002141913.USD","LU1852331112.SGD","07522","LU0719512351.SGD","SGXZ23171101.USD","LU0444971666.USD","LU1642822529.SGD","SNPX","LU2362541273.HKD","LU0082616367.USD","LU0511384066.AUD","LU2458330169.SGD","LU1803068979.SGD","LU2506952170.USD","NJUL","GPIQ","LU0056508442.USD","LU0823417653.USD","IE00BFTCPJ56.SGD","LU0354030511.USD","BK4600","ALNY","LU0347712357.USD","LU0210535034.USD","LU0057025933.USD","LU1061106388.HKD","BK4543","LU2298322129.HKD","LU1093756168.USD","BK4581","LU1571399168.USD","LAZR","LU0079474960.USD","LU2360106780.USD","LU2433249047.HKD","LU2506951875.HKD","TQQY","QQQM","LU2764263039.SGD","LU1712237335.SGD","LU2506952337.HKD","MELI","MSII","LU2279701549.SGD","LU0823416689.USD","QQQ","AMGN","LU0823417737.USD","07266","CRPT","QQQX","LITX","LU2720916845.USD","IE00BQXX3F31.USD","LU1983299246.USD","IE00BQXX3C00.GBP","LU2360107168.USD","LU0882574055.USD","IE0008368304.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU2355687059.USD","QMAR","LU1093756325.SGD","LU0289739343.SGD","LU1861217088.USD","IE00BJJMRZ35.SGD","LITG","IE00B8HQ1Z84.USD","SMST","02834","MST","LU1023059063.AUD","LU2543165471.USD","LU0532187761.SGD","IE00BZ9MQY76.HKD","KMLI","BK4023","LU0143863784.USD","07799","SG9999000418.SGD","NDX","LU0354030438.USD","LU0823414551.USD","LU0096362180.USD","SGXZ99366536.SGD","LU0889565833.HKD","LU0724618433.USD","LU2089984988.USD","LU2456880835.USD","BK4608","LU1951200564.SGD","3SMI.UK","APPX","LU2413666699.HKD","IBBQ","LU0114720955.EUR","BK4567","LU1815333072.USD","GNMX","LU2237438978.USD","BK4595","LU0889565916.HKD","PBE","LU2764262908.HKD","IE00BZ199S13.USD","09086","IE00BD6J9T35.USD","LU0823414478.USD","MSTK","IE00B19Z3B42.SGD","LU2125909759.SGD","PJP","PRNT","IE00BGV7N243.SGD","3LMI.UK","LU0957808578.USD","LU0109392836.USD","LU2112291526.USD","MSTC","LU1854103824.USD","LU2275660780.HKD","LU2210150020.SGD","LU2506951958.HKD","NOCT","LU0234570918.USD","LU1923623000.USD","LU2357125470.USD","QDEC","07568","BK4139","BK4533","IE00B19Z3581.USD","LU2324357040.USD","09834","VRTX","IE00BN0W2V16.EUR","IE0009356076.USD","MSDD","BK4122","LU1430594728.SGD","LU2236285917.USD","LU2506951792.HKD","LMI3.UK","LU0323239441.USD","LU2417539215.USD","LU0050427557.USD","CDNS","SNPS","BK4596","MSOO","LU1633808545.USD","EGGY","IE00BN0W2T93.GBP","LU1721428933.USD","LU1585245621.USD","09399","LU0868494617.USD","LU2458330243.SGD","LU0950375773.USD","LU1815336760.USD","LU2477742899.HKD","LU0094547139.USD","LITE","BK4532","LU0205193047.USD","LU1778281490.HKD","LU2265009873.SGD","PSQ","MSTW","LU0312595415.SGD","LU1035775433.USD","LU2462157665.USD","SG9999001176.SGD","LU1923622291.USD","TBXU","LU0106261612.USD","LU1861215975.USD","LU0353189680.USD","BK4588","GB00BDT5M118.USD","LU1989764664.SGD","LU0342679015.USD","BK4613","IE00B0JY6N72.USD","LU2290526834.HKD","MTYY","OWNB","MSST","LU2063271972.USD","TQQQ","LU0106959298.USD","03086","SG9999004303.SGD","LU1861219969.SGD","CDNG","LU2506952097.USD","LU0124384867.USD","BK4585","LU1821325948.USD","LU0097036916.USD","LU1303367103.USD","LU0154236417.USD","LU0143863198.USD","BK4206","LU0175139822.USD","LU1854104046.USD","APPC","LU1861214812.USD","LU0390134368.USD","XDAT","LU0240877869.USD","LU0289739699.SGD","LU1674673428.USD","LU0170899867.USD","LU0353189763.USD","IE00B19Z9P08.USD","SGXZ51526630.SGD","LU0552385451.USD","NAPR","LU0012050646.USD","LU2095319765.USD","LU0122379950.USD","LU2211814178.USD","LU1069344957.HKD","IE00BQXX3D17.EUR","LU1868837722.USD","IE00BN0W2W23.USD","QLD","LU2764263203.CNY","LU0320765992.SGD","LU2242652126.USD","IE00B8L5B284.USD","LU0786609619.USD","LU2125909593.SGD","LU0289960550.SGD","SGXZ81514606.USD","LU2360107325.USD","BITQ","LU2413666426.HKD","IE0004445239.USD","LU0061474960.USD","LU0823411888.USD","IMST","BIB","IBB","LU2362541513.USD","QID","NJAN","BK4566","LU1721428347.USD","LU1978683503.SGD","BK4534","LU0456842615.SGD",".HXC","LU0957791311.USD","IE00BKPKM429.USD","LU0323240290.USD","MSTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766092","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766092","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766092?lang=en_us&edition=fundamental","pubTime":"2026-10-02 01:12","pubTimestamp":1790874723,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  dropping 1.1%.The iShares Biotechnology ETF  shed 1.2%.In corporate news, Pfizer  is facing a lawsuit filed by Florida Attorney General James Uthmeier alleging deceptive marketing practices related to COVID-19 vaccines, the attorney general's office said Thursday on X. Pfizer shares were down 1.1%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BLSP4239.USD","LU1066053197.SGD","LU2596442595.SGD","LU0029874061.USD","BK4599","XBI","LU0225284248.USD","SG9999003800.SGD","IE00B3T34201.USD","LU0170899867.USD","LU1057294990.SGD","LU1066051498.USD","IE0002270589.USD","LU0122379950.USD","IE00B19Z3581.USD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","BK4137","LU0985481810.HKD","LU1023059063.AUD","LU1894683264.USD","SG9999011175.SGD","LU1894683348.USD","LU0128526141.USD","SG9999013999.USD","BK4568","BK4581","OZEM","BK4533","LU0321505868.SGD","BK4592","LU0868494617.USD","LU0289739699.SGD","PFE","SG9999001176.USD","LABU","LU0456855351.SGD","XLV","SG9999002232.USD","BK4585","BK4007","BK4550","LU0306807586.USD","IBB","LU0225771236.USD","SG9999001176.SGD","SGXZ57979304.SGD","SG9999002224.SGD","LU0058720904.USD","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","HCSG","BK4534","IE000M9KFDE8.USD","BK4588","LU0306806265.USD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672791766","title":"Regeneron price target raised to $930 from $870 at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2672791766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672791766?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:50","pubTimestamp":1790873422,"startTime":"0","endTime":"0","summary":"Jefferies raised the firm’s price target on Regeneron (REGN) to $930 from $870 and keeps a Buy rating on the shares. The company’s expanded collabo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-price-target-raised-to-930-from-870-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-price-target-raised-to-930-from-870-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU2362540622.SGD","LU0889565916.HKD","LU0114720955.EUR","LU0823434583.USD","LU0289739699.SGD","IBBQ","LU1917777945.USD","IBB","TBXU","LU0058720904.USD","LU0882574055.USD","LU2106854487.HKD","LU2362541513.USD","BK4139","LU1974910355.USD","LU0109394709.USD","LU2237438978.USD","LU2362541273.HKD","LU0053666078.USD","LU0823416689.USD","LU0823434740.USD","LU0320765992.SGD","BK4588","LU2089984988.USD","LU2023250504.SGD","LU2468319806.SGD","BK4585","REGN","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672476612","title":"Amgen’s Pediatric Psoriasis Study in Japan Wraps Up, Setting the Stage for Otezla Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2672476612","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672476612?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:30","pubTimestamp":1790872227,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has completed a Phase 3 study called “A Phase 3, Multicent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-in-japan-wraps-up-setting-the-stage-for-otezla-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-in-japan-wraps-up-setting-the-stage-for-otezla-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","BK4533","BK4588","PBE","BK4585","LU1061106388.HKD","IBBQ","LU0122379950.USD","IE00B2B36J28.USD","LU0868494617.USD","BK4581","IE0002141913.USD","LU2242652126.USD","BBH","LU0109394709.USD","LU0889565916.HKD","LU1023059063.AUD","IE00BJJMRZ35.SGD","BK4599","LU2242646821.SGD","LU1571399168.USD","TBXU","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","AMGN","BIB","LU2089984988.USD","BK4139","PJP","LU0058720904.USD","LU1983299246.USD","LU2112291526.USD","BK4534","BK4566","LU1057294990.SGD","LU2468319806.SGD","SG9999001440.SGD","IBB","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672197766","title":"Expanded Sanofi agreement particularly favorable for Regeneron, says TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2672197766","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672197766?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:20","pubTimestamp":1790871634,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren reiterated a Buy rating and $960 price target on Regeneron (REGN), saying the expanded agreement with Sanofi (SNY)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/expanded-sanofi-agreement-particularly-favorable-for-regeneron-says-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/expanded-sanofi-agreement-particularly-favorable-for-regeneron-says-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","REGN","BK4585","LU2089984988.USD","LU0882574055.USD","BK4007","LU0109394709.USD","BK4127","LU2324357040.USD","IBB","LU2023250504.SGD","COWN","LU0823434583.USD","LU0889565916.HKD","LU0114720955.EUR","LU1974910355.USD","LU0320765992.SGD","BK4588","SNY","TBXU","LU0823416689.USD","LU0058720904.USD","IE00BFXG1179.USD","LU2237438978.USD","LU2106854487.HKD","SNYNF","LU2362540622.SGD","LU0823434740.USD","LU2468319806.SGD","LU1917777945.USD","BK4139","LU2362541513.USD","IBBQ","LU0289739699.SGD","LU0053666078.USD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672076575","title":"Walt Disney, Amgen Share Losses Lead Dow's 150-Point Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2672076575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672076575?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:09","pubTimestamp":1790870940,"startTime":"0","endTime":"0","summary":"DJ Walt Disney, Amgen Share Losses Lead Dow's 150-Point FallThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Walt Disney and Amgen are trading lower Thursday afternoon, sending the Dow Jones Industrial Average into negative territory.Shares of Walt Disney  and Amgen  are contributing to the index's intraday decline, as the Dow  was most recently trading 150 points lower .Walt Disney's shares are off $3.07  while those of Amgen are off $9.88 , combining for a roughly 77-point drag on the Dow.Also contributing significantly to the decline are Home Depot , American Express , and Apple .A $1 move in any of the index's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOX","LU0320765489.SGD","BK4524","GB00BDT5M118.USD","LU0786609619.USD","AMGN","SG9999015952.SGD","LU2133065610.SGD","BK4598","LU1983299246.USD","LU0208291251.USD","LU2242646821.SGD","LU1057294990.SGD","LU0742534661.SGD","LU0210533765.USD","IE00B4R5TH58.HKD","LU1718418525.SGD","IE00BJT1NW94.SGD","LU1894683264.USD","LU2347655156.SGD","IE0002270589.USD","LU0070302665.USD","DIS","LU2347655073.USD","SG9999015945.SGD","LU2089984988.USD","LU1571399168.USD","LU2357305700.SGD","LU0726765562.USD","LU0310800379.SGD","SG9999001440.SGD","DISO","FCOM","BK4554","BK4108","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0320765992.SGD","LU0889565916.HKD","LU0314106906.USD","WNDR","BK4566","BK4534","LU0122379950.USD","SG9999015978.USD","LU2112291526.USD","TBXU","LU1548497426.USD","LU1720051108.HKD","BK4585","LU2468319806.SGD","BK4561","LU0058720904.USD","LU0868494617.USD","SG9999015986.USD","LU1023059063.AUD","BK4507","LU0109394709.USD","IE0009355771.USD","BK4599","LU0708994859.HKD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0251142724.SGD","LU0795875086.SGD","IE00BZ1G4Q59.USD","BK4551","LU0048573561.USD","BK4532","IE00B7SZLL34.SGD","LU0251131958.USD","LU1894683348.USD","LU1280957306.USD","LU0795875169.SGD","LU1069347547.HKD","LU0640476718.USD","BK4581","LU1035773651.USD","04332","LU0011850046.USD","IBB","BBH","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4533","BIB","LU0912757837.SGD","IBBQ","BK4139","IE0002141913.USD","LU2242652126.USD","BK4550","LU1732799900.SGD","LU1732800096.USD","LU0061475181.USD","PBE","PJP","BK4588","IE00BKVL7J92.USD","LU1061106388.HKD","LU1267930573.SGD","LU1506573853.SGD","LU1720051017.SGD","LU0070217475.USD","LU0128525929.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765508","title":"Regeneron says COURAGE trial confirms trevogrumab prevents muscle loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765508?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868917,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Pharmaceuticals announced new results from the Phase 2 COURAGE trial evaluating trevogrumab for its potential to prevent lean mass...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-says-courage-trial-confirms-trevogrumab-prevents-muscle-loss-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-says-courage-trial-confirms-trevogrumab-prevents-muscle-loss-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","REGN","LU0053666078.USD","LU2362541513.USD","LU2023250504.SGD","LU2468319806.SGD","LU2237438978.USD","LU0823416689.USD","LU2324357040.USD","BK4588","LU0823434583.USD","LU0289739699.SGD","BK4139","LU1974910355.USD","LU0109394709.USD","IBBQ","LU0882574055.USD","LU2089984988.USD","BK4585","LU0823434740.USD","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","LU1917777945.USD","LU2362541273.HKD","LU2106854487.HKD","LU0889565916.HKD","BBH","IBB","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765334","title":"Regeneron Pharmaceuticals, - 9-Month Median Duration of Response Observed at 800 Mg Ubamatamab Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765334?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU1974910355.USD","BBH","LU2468319806.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0823434583.USD","BK4585","BK4588","REGN","IBB","LU2362541273.HKD","LU0289739699.SGD","LU0882574055.USD","LU0823434740.USD","LU1917777945.USD","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU2324357040.USD","TBXU","BK4139","LU0114720955.EUR","LU2362541513.USD","LU2362540622.SGD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672653377","title":"Regeneron Pharmaceuticals, - Ubamatamab Shows 73% Objective Response Rate and 11-Month Median Pfs in Lgsoc Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672653377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672653377?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053666078.USD","LU2106854487.HKD","LU0889565916.HKD","LU2237438978.USD","TBXU","LU2324357040.USD","LU2362541273.HKD","LU0114720955.EUR","LU0823416689.USD","LU0320765992.SGD","IBBQ","LU2362540622.SGD","LU2468319806.SGD","LU0289739699.SGD","BBH","BK4585","LU0058720904.USD","BK4588","LU1974910355.USD","LU2023250504.SGD","LU2362541513.USD","BK4139","LU0823434583.USD","REGN","LU0109394709.USD","LU1917777945.USD","IBB","LU2089984988.USD","LU0823434740.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672653197","title":"Regeneron Pharmaceuticals, - Serious Teaes Grade 3+ in 21% of Lgsoc Patients; Traes in 74%; Neutropenia, Anemia, Elevated Liver Enzymes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672653197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672653197?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0058720904.USD","LU0823434583.USD","BBH","LU0109394709.USD","REGN","LU2362540622.SGD","LU2023250504.SGD","LU1974910355.USD","LU0823434740.USD","LU0823416689.USD","LU0889565916.HKD","LU2237438978.USD","LU2324357040.USD","LU2362541513.USD","LU2362541273.HKD","BK4588","IBB","BK4585","LU2106854487.HKD","BK4139","TBXU","IBBQ","LU0289739699.SGD","LU1917777945.USD","LU0053666078.USD","LU2468319806.SGD","LU0882574055.USD","LU0320765992.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672314765","title":"Regeneron Pharmaceuticals, - to Advance Ubamatamab into Confirmatory Phase 3 Trial for Lgsoc","url":"https://stock-news.laohu8.com/highlight/detail?id=2672314765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672314765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","IBBQ","TBXU","LU0889565916.HKD","LU0823416689.USD","LU0320765992.SGD","BBH","LU0109394709.USD","LU2106854487.HKD","LU1974910355.USD","LU2362541513.USD","REGN","LU0882574055.USD","LU0058720904.USD","IBB","BK4585","LU2089984988.USD","LU2468319806.SGD","LU0823434740.USD","LU2023250504.SGD","BK4588","LU2362540622.SGD","LU0289739699.SGD","LU0053666078.USD","BK4139","LU0823434583.USD","LU1917777945.USD","LU2237438978.USD","LU2362541273.HKD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672176533","title":"Ubamatamab (Muc16xcd3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (Lgsoc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672176533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672176533?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU2468319806.SGD","LU0114720955.EUR","BK4585","LU0823434583.USD","LU0823434740.USD","LU2237438978.USD","IBB","IBBQ","LU0889565916.HKD","BBH","LU1917777945.USD","LU2023250504.SGD","LU2106854487.HKD","LU0053666078.USD","LU2324357040.USD","TBXU","LU0058720904.USD","LU2089984988.USD","LU2362541513.USD","LU0109394709.USD","LU1974910355.USD","BK4139","LU2362540622.SGD","LU2362541273.HKD","BK4588","LU0823416689.USD","REGN","LU0882574055.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765309","title":"Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765309","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765309?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":"LGSOC is a biologically distinct variant of ovarian cancer, with limited treatment options, that is generally less responsive to conventional chemotherapy Results presented in a late-breaking plenary ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3373161/0/en/ubamatamab-muc16xcd3-shows-a-high-rate-of-durable-responses-in-initial-study-of-patients-with-advanced-low-grade-serous-ovarian-cancer-lgsoc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2931357623.SGD","LU0058720904.USD","IE00B7SZL793.SGD","LU0320765992.SGD","LU0823434583.USD","LU0823434740.USD","NOBL","AEIS","LU1974910355.USD","LU2362541513.USD","LU0889565916.HKD","LU2468319806.SGD","LU0114720955.EUR","BK4585","LU0274383776.USD","LU2023250504.SGD","LU2362541273.HKD","LU0109394709.USD","IE00B66KJ199.SGD","LU0289739699.SGD","IE00B19Z4B17.USD","TBXU","LU1917777945.USD","LU2362540622.SGD","LU2324357040.USD","REGN","BBH","IBB","IXJ","LU0053666078.USD","LU0823416689.USD","BK4139","TCAF","LU2106854487.HKD","BK4104","IBBQ","LU0882574055.USD","LU1815336091.USD","BK4588","LU2237438978.USD","BCC","BK4567","LU0757428866.USD","LU2089984988.USD","BK4550","BK4157","LU2089985449.USD","CGCV","IE0031619046.USD","VHT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}